TimeTech Business Valuation and the Strategic Fundraising Gate
Strategic-level simulation · From FCFF, WACC and multi-method valuation through the equity bridge, sensitivity analysis and investment negotiation
As TimeTech's valuation analyst, you reconcile the post-acquisition combined management figures and the five-year forecast as at the 31 December 2027 valuation date, complete DCF, comparable-company, comparable-transaction and asset-based valuations, build the enterprise-value-to-equity-value bridge, quantify the patent expiry and the forecast bias, assess the strategic investor's offer of US$50 million for 20% of the equity, and frame a non-binding negotiation and a pause gate.
The question
The post-acquisition combined management figures for 2027 are: revenue of US$60 million, EBITDA of US$15 million, net profit of US$10 million, total assets of US$50 million, total liabilities of US$20 million, net assets of US$30 million, capital expenditure of US$5 million, depreciation and amortisation of US$3 million, and an increase in working capital of US$2 million. These are in-case management figures that still require finance verification; they are not facts about a real company or an audit opinion.
Company background
TimeTech Ltd. develops, manufactures and sells smart wearable devices and provides online health-management services. The acquisition of HealthCare Ltd. was completed on 30 September 2027; the subject of this valuation is the whole of TimeTech after the acquisition, not a fresh assessment of whether to acquire HealthCare.
Techniques
现金流、资本成本与 DCF多方法估值与口径校准股权桥、数据质量与风险战略投资谈判与治理取证与管理层沟通Who it suits
Recommended for learners who already have a solid grounding in F3 business valuation, the cost of capital and the fundamentals of acquisition accounting and are now preparing for the Strategic level ; it emphasises modelling discipline, the boundaries of evidence, investment terms and communication with management.
All courses
- TimeTech M&A Evaluation, Integration and Restructuring Gateways
- TimeTech Organisational Structure Design and Change Pilot
- TimeTech Mutually Exclusive Production Investment Decision
- TimeTech IPO Readiness, R&D Investment and Capital Allocation
- TimeTech T-100 Cost Diagnosis
- TimeTech 2025 Master Budget Preparation and Control